Stocks
Funds
Screener
Sectors
Watchlists

Latest Ally Bridge Group (NY) LLC Stock Portfolio

Ally Bridge Group (NY) LLC Performance:
2024 Q4: 0.81%YTD: 18.59%2023: 23.22%

Performance for 2024 Q4 is 0.81%, and YTD is 18.59%, and 2023 is 23.22%.

About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings

Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $116.6 Millions as of 31 Dec, 2024.

The top stock holdings of Ally Bridge Group (NY) LLC are ITCI, TARS, INSM. The fund has invested 10.6% of it's portfolio in INTRA-CELLULAR THERAPIES INC and 8.2% of portfolio in TARSUS PHARMACEUTICALS INC.

The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), LONGBOARD PHARMACEUTICALS IN (LBPH) and REVOLUTION MEDICINES INC (RVMD) stocks. They significantly reduced their stock positions in SPRINGWORKS THERAPEUTICS INC (SWTX), JASPER THERAPEUTICS INC (JSPR) and MIND MEDICINE MINDMED INC (MNMD). Ally Bridge Group (NY) LLC opened new stock positions in INTRA-CELLULAR THERAPIES INC (ITCI), AXSOME THERAPEUTICS INC (AXSM) and SOLENO THERAPEUTICS INC (SLNO). The fund showed a lot of confidence in some stocks as they added substantially to ALUMIS INC.

Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Ally Bridge Group (NY) LLC made a return of 0.81% in the last quarter. In trailing 12 months, it's portfolio return was 18.59%.

New Buys

Ticker$ Bought
intra-cellular therapies inc12,340,100
axsome therapeutics inc5,640,190
soleno therapeutics inc3,938,920
korro bio inc2,690,710
eyepoint pharmaceuticals inc2,592,600
aadi bioscience inc2,580,600
atyr pharma inc2,533,020
89bio inc2,485,450

New stocks bought by Ally Bridge Group (NY) LLC

Additions

Ticker% Inc.
alumis inc6.42

Additions to existing portfolio by Ally Bridge Group (NY) LLC

Reductions

Ticker% Reduced
springworks therapeutics inc-75.98
jasper therapeutics inc-69.35
mind medicine mindmed inc-58.11
edgewise therapeutics inc-55.69
blueprint medicines corp-47.31
tarsus pharmaceuticals inc-46.21
merus n v-43.91
trevi therapeutics inc-40.92

Ally Bridge Group (NY) LLC reduced stake in above stock

Sold off

Ticker$ Sold
relay therapeutics inc-4,432,490
applied therapeutics inc-5,255,820
perspective therapeutics inc-4,562,220
kura oncology inc-5,746,340
longboard pharmaceuticals in-8,028,930
revolution medicines inc-7,414,720
disc medicine inc-4,914,000
sarepta therapeutics inc-8,992,080

Ally Bridge Group (NY) LLC got rid off the above stocks

Sector Distribution

Ally Bridge Group (NY) LLC has about 85.7% of it's holdings in Healthcare sector.

Sector%
Healthcare85.7
Others14.3

Market Cap. Distribution

Ally Bridge Group (NY) LLC has about 6.8% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP37.3
SMALL-CAP28.4
UNALLOCATED14.3
MICRO-CAP9.8
LARGE-CAP6.8
NANO-CAP3.5

Stocks belong to which Index?

About 57% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200057
Others43
Top 5 Winners (%)%
TARS
tarsus pharmaceuticals inc
58.3 %
AADI
aadi bioscience inc
48.6 %
PRAX
praxis precision medicines i
30.1 %
MNMD
mind medicine mindmed inc
22.3 %
LIFE
atyr pharma inc
18.3 %
Top 5 Winners ($)$
TARS
tarsus pharmaceuticals inc
6.2 M
PRAX
praxis precision medicines i
1.3 M
MNMD
mind medicine mindmed inc
1.0 M
JSPR
jasper therapeutics inc
1.0 M
JANX
janux therapeutics inc
0.9 M
Top 5 Losers (%)%
ELYM
climb bio inc
-49.5 %
CNTX
context therapeutics inc
-42.3 %
TYRA
tyra biosciences inc
-38.0 %
PMN
promis neurosciences inc
-24.2 %
GERN
geron corp
-19.8 %
Top 5 Losers ($)$
ELYM
climb bio inc
-3.1 M
TYRA
tyra biosciences inc
-2.4 M
CNTX
context therapeutics inc
-1.5 M
MRUS
merus n v
-1.2 M
GERN
geron corp
-1.2 M

Ally Bridge Group (NY) LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC has 30 stocks in it's portfolio. About 55.1% of the portfolio is in top 10 stocks. ELYM proved to be the most loss making stock for the portfolio. TARS was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.

Last Reported on: 14 Feb, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions